Canton Strategic Holdings (CNTN) Profit After Tax Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 65.80% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 17.05% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,228.66% |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | -1,762.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,762.66% |
| Dec 31, 2025 | -669.98% |
| Sep 30, 2025 | 44.63% |
| Jun 30, 2025 | 20.21% |
| Mar 31, 2025 | -12.66% |
| Dec 31, 2024 | -54.44% |
| Sep 30, 2024 | -108.55% |
| Jun 30, 2024 | 0.51% |
| Mar 31, 2024 | 16.08% |
| Dec 31, 2023 | -40.04% |
| Sep 30, 2023 | 14.45% |
| Jun 30, 2023 | -42.77% |
| Mar 31, 2023 | 8.64% |
| Dec 31, 2022 | -172.01% |
| Sep 30, 2022 | -149.28% |
| Jun 30, 2022 | -5.19% |
| Mar 31, 2022 | -30.77% |